Clofoctol is an antibacterial agent primarily used in the treatment of upper respiratory tract infections, such as sinusitis, pharyngitis, and bronchitis. It is effective against Gram-positive bacteria and certain Gram-negative strains, helping to reduce bacterial load and alleviate symptoms. The compound also possesses anti-inflammatory properties, aiding in the reduction of swelling and pain associated with infections. Clofoctol is typically administered orally in capsule form for adults and children over 6 years of age. Its mechanism of action involves inhibiting bacterial RNA synthesis, exerting a bacteriostatic effect. Use should be under medical supervision to minimize side effects and prevent antibiotic resistance. While primarily oral, it has been explored in topical formulations for localized infections.